2 most recent filings and news items mentioning TNXP. Updated every 60 seconds.
RegulatoryJun 8, 2026Positive
Tonix Pharmaceuticals announced a second commercial payer agreement effective June 1, 2026, adding approximately 17 million U.S. lives in coverage for its fibromyalgia drug TONMYA, bringing total commercial coverage to ~52 million lives (29% of U.S. commercial market). The milest
View filing at SEC.gov →
RegulatoryMay 27, 2026Positive
Tonix announced publication of Phase 1 clinical data for TNX-1500 in the Journal of Clinical Immunology, showing the drug was well-tolerated with favorable safety profile. A Phase 2 investigator-initiated kidney transplant study at Massachusetts General Hospital is expected to be
View filing at SEC.gov →
AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.